FTSE All-Share
|
5 215,78
|
36,48
|
0,70 %
|
Analysen zu FTSE All-Share-Werten
| 09.04.25 | Rio Tinto Buy | Deutsche Bank AG | |
| 09.04.25 | AstraZeneca Outperform | Bernstein Research | |
| 09.04.25 | HSBC Holdings Buy | Jefferies & Company Inc. | |
| 08.04.25 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 08.04.25 | Diageo Buy | Jefferies & Company Inc. | |
| 08.04.25 | Shell Outperform | RBC Capital Markets | |
| 08.04.25 | HSBC Holdings Buy | Goldman Sachs Group Inc. | |
| 08.04.25 | HSBC Holdings Sector Perform | RBC Capital Markets | |
| 07.04.25 | GSK Hold | Deutsche Bank AG | |
| 07.04.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 07.04.25 | London Stock Exchange Buy | UBS AG | |
| 07.04.25 | Shell Outperform | RBC Capital Markets | |
| 07.04.25 | Barclays Overweight | JP Morgan Chase & Co. | |
| 07.04.25 | Shell Buy | Jefferies & Company Inc. | |
| 07.04.25 | London Stock Exchange Buy | Jefferies & Company Inc. | |
| 04.04.25 | BP Sector Perform | RBC Capital Markets | |
| 04.04.25 | GSK Hold | Deutsche Bank AG | |
| 04.04.25 | BP Buy | Jefferies & Company Inc. | |
| 04.04.25 | Glencore Buy | Jefferies & Company Inc. | |
| 04.04.25 | Rio Tinto Buy | Jefferies & Company Inc. | |
| 03.04.25 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 03.04.25 | AstraZeneca Outperform | Bernstein Research | |
| 03.04.25 | GSK Outperform | Bernstein Research | |
| 03.04.25 | Diageo Buy | UBS AG | |
| 03.04.25 | Glencore Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 03.04.25 | Rio Tinto Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 02.04.25 | Shell Buy | Goldman Sachs Group Inc. | |
| 02.04.25 | BP Buy | Goldman Sachs Group Inc. | |
| 02.04.25 | Diageo Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 02.04.25 | Unilever Overweight | JP Morgan Chase & Co. | |
| 01.04.25 | AstraZeneca Buy | UBS AG | |
| 01.04.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 01.04.25 | BP Neutral | JP Morgan Chase & Co. | |
| 01.04.25 | Shell Overweight | JP Morgan Chase & Co. | |
| 31.03.25 | HSBC Holdings Neutral | UBS AG | |
| 31.03.25 | Vodafone Group Buy | Deutsche Bank AG | |
| 28.03.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 28.03.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 28.03.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 28.03.25 | AstraZeneca Buy | Goldman Sachs Group Inc. |
HOT STOCKS DER LETZTEN 3 TAGE
| Unilever | 12 |
| London Stock Exchange | 6 |
| GSK | 5 |
| AstraZeneca | 3 |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.